Evaluation of Fifteen 5,6-Dihydrotetrazolo[1,5-c]quinazolines Against Nakaseomyces glabrata: Integrating In Vitro Studies, Molecular Docking, QSAR, and In Silico Toxicity Assessments

Lyudmyla Antypenko, Oleksii Antypenko, Alina Fominichenko, Iryna Karnaukh, Serhii Kovalenko, Mieko Arisawa · 2024

Read Evaluation of Fifteen 5,6-Dihydrotetrazolo[1,5-c]quinazolines Against Nakaseomyces glabrata: Integrating In Vitro Studies, Molecular Docking, QSAR, and In Silico Toxicity Assessments by Lyudmyla Antypenko, Oleksii Antypenko, Alina Fominichenko, Iryna Karnaukh, Serhii Kovalenko, Mieko Arisawa (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11728297.txt.

Description

Lyudmyla Antypenko and five co-authors present a 2024 study of fifteen related compounds tested against a drug resistant yeast. The yeast is the second most common Candida threat in clinics and often shrugs off the standard azole drugs. New chemical families are needed that can still stop it.

The team made two new compounds and characterized them with several spectral tools. All fifteen were tested on patient isolates of the yeast across a range of doses. Two stood out, stopping growth at doses about twenty times lower than weak peers. Computer docking, pattern models, and toxicity screens rounded out the checks on the best candidates.

Catalog record

CREATORLyudmyla Antypenko, Oleksii Antypenko, Alina Fominichenko, Iryna Karnaukh, Serhii Kovalenko, Mieko Arisawa
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11728297

Browse the full library · About the Tower of Babel